NCT06790212 Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06769971 Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC Status RECRUITING Phase PHASE2
NCT06672575 A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT06567314 Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06529718 Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients Status RECRUITING Phase PHASE2
NCT06491472 Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer Status RECRUITING Phase PHASE2
NCT06478043 A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC Status NOT_YET_RECRUITING Phase PHASE2
NCT06196697 AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer Status RECRUITING Phase PHASE2
NCT05582499 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy Status RECRUITING Phase PHASE2